IO BIOTECH INC (IOBT) Stock Analyst Earnings Estimates
NASDAQ:IOBT - Nasdaq - US4497781090 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A 293.66% | N/A 97.98% | N/A 67.26% | N/A 39.31% | N/A 11.21% | N/A 23.77% | ||||||
| EBITDA YoY % growth | N/A | N/A | N/A | -71.32M -33.45% | -91.228M -27.91% | N/A -3.13% | N/A 3.42% | N/A -14.05% | N/A 4.98% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -9.91M | -10.15M -2.42% | -41.23M -306.21% | -71.42M -73.22% | -91.443M -28.04% | N/A -5.50% | N/A -4.68% | N/A -17.44% | N/A 13.70% | N/A 49.30% | N/A 113.96% | N/A 1,209.95% | N/A 65.23% | N/A 53.31% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -2.50 46.25% | -2.16 13.60% | -1.45 32.87% | N/A 7.43% | N/A 20.36% | N/A 34.35% | N/A 75.29% | N/A 452.94% | N/A 150.00% | N/A | N/A |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.36 -17.14% | -0.36 -0.30% | -0.30 37.10% | -0.29 16.00% |
| Revenue Q2Q % growth | ||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -24.786M -15.11% | -27.166M -2.50% | -29.376M -9.03% | -33.354M -47.69% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.34 -13.33% | -0.39 | 0.05 | 12.28% |
| Q4 2024 Q2Q % growth | -0.48 -20.00% | -0.40 | -0.08 | -20.66% |
| Q3 2024 Q2Q % growth | -0.36 16.28% | -0.29 | -0.07 | -22.76% |
| Q2 2024 Q2Q % growth | -0.31 58.11% | -0.36 | 0.05 | 13.17% |
| Q1 2024 Q2Q % growth | -0.30 49.15% | -0.37 | 0.07 | 18.30% |
| Q4 2023 Q2Q % growth | -0.40 42.86% | -0.40 | 0.00 | -1.07% |
| Q3 2023 Q2Q % growth | -0.43 23.21% | -0.45 | 0.02 | 5.05% |
| Q2 2023 Q2Q % growth | -0.74 -15.62% | -0.67 | -0.07 | -9.92% |
| Q1 2023 Q2Q % growth | -0.59 1.67% | -0.72 | 0.13 | 17.95% |
| Q4 2022 Q2Q % growth | -0.70 32.72% | -0.60 | -0.10 | -16.32% |
| Q3 2022 Q2Q % growth | -0.56 98.48% | -0.68 | 0.12 | 18.06% |
| Q2 2022 Q2Q % growth | -0.64 | -0.69 | 0.05 | 7.27% |
| Q1 2022 Q2Q % growth | -0.60 | -0.67 | 0.07 | 10.42% |
| Q3 2021 Q2Q % growth | -36.88 | -1.63 | -35.25 | -2,159.80% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 13.17% | 0% | 0% |
| Revenue | N/A | N/A | N/A | N/A |